Neuroprotective effects of the gliopeptide octadecaneuropeptide in an in vivo model of Parkinson disease

Seyma Bahdoudi (1) , Ikram Ghouili (2) , Jean-Luc Do Rego , Jérôme Leprince (1) , Jean-Claude Do Rego (3) , Suzanne Manrup (4) , Hubert Vaudry , Marie-Christine Tonon (1, 5) , Olfa Masmoudi-Kouki (6) , David Vaudry (1)

1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 UTM - Université de Tunis El Manar
3 SCAC - Service Commun d'Analyse Comportementale
4 SDU - University of Southern Denmark
5 DC2N - Différenciation et communication neuronale et neuroendocrine
6 Department of Biological Sciences

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Neurons and Cognition [q-bio.NC]

Seyma Bahdoudi, Ikram Ghouili, Jean-Luc Do Rego, Jérôme Leprince, Jean-Claude Do Rego, et al.. Neuroprotective effects of the gliopeptide octadecaneuropeptide in an in vivo model of Parkinson disease. International Regulatory Peptide Society Congress, Jul 2016, Rouen, France. ⟨hal-02349171⟩